LALPATHLABDr. Lal Path Labs Ltd.
Healthcare · Diagnostics & Research · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹1,697.10
▲ 0.57%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)28,175.80
P/E55.97
P/B11.23
PEG—
ROE %21.47
ROCE %37.90
Debt / Equity0.08
EPS30.15
Revenue Growth %16.60
Profit Growth %-15.40
Dividend Yield %0.83
Promoter Holding %54.90
FII Holding %31.45
DII Holding %—
Beta0.19
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 65% | ₹1,697.10 | ₹1,645.47 | ₹1,782.90 | 1.66 |
HOLDConviction 77%
The picture
- • Revenue growth: 16.6% YoY
- • ROE: 21.5%
- • ROCE: 37.9%
- • RSI: 55
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 65%)
Bull case
- • Revenue growth: 16.6% YoY
- • ROE: 21.5%
- • ROCE: 37.9%
- • RSI: 55
Bear case
- • Profit growth: -15.4% YoY
- • MACD: bearish
- • Volume: 0.5x 20-day average
- • Volume trend: 0.5x baseline
Key risks
- • Profit growth: -15.4% YoY
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹1,697.10
Stop Loss
₹1,594.00
risk 6.1%
Target 1 (1.5R)
₹1,851.75
+9.1%
Target 2 (3R)
₹2,006.40
+18.2%
Support (20d)
₹1,610.10
Resistance (52w)
₹1,798.66
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹103.10/share
ATR (volatility)
₹51.63
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹51.63). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
70
Technical
63
Momentum
75
Risk (safety)
69